<sup>18</sup> F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
The development of <sup>18</sup>F-labelled radiotracers is of vital importance for (pre)clinical positron emission tomography (PET) imaging and to guide drug discovery campaigns. State-of-the-art approaches often require labour-intensive preparation of highly functionalised radiolabelling precursors. This bottleneck impedes analogue generation for optimal imaging and exploration of radiochemical space. To this end, we disclose a nickel-mediated aryl (C)sp<sup>2</sup>-(C)sp<sup>3</sup> cross-coupling with amine-derived alkyl 2,4,6-triphenylpyridinium salts as coupling partners amenable to radiosynthesis. The method was applied to primary and secondary 2,4,6-triphenylpyridinium salts in radiochemical conversion (RCC) up to 86% and a high-throughput experimentation (HTE) assay proved crucial for expedient ligand evaluation. A late-stage diversification case study from a sole precursor achieved six <sup>18</sup>F-labelled GSK-3 kinase inhibitor analogues, one being prepared in up to gigabecquerel (GBq) quantities in a (semi)automated two-step protocol applied across three commercial radiosynthesis platforms.
Authors
- Rhys Salter
- Joseph Ford (ORCID: https://orcid.org/0000-0001-7959-2085)
- Peter Buijnsters (ORCID: https://orcid.org/0000-0003-1383-0823)
- Sebastiano Ortalli
- Véronique Gouverneur (ORCID: https://orcid.org/0000-0001-8638-5308)
- Andrés A. Trabanco (ORCID: https://orcid.org/0000-0002-4225-758X)
- Alexandre M. Sorlin (ORCID: https://orcid.org/0000-0002-9589-6131)
- Matthew Tredwell (ORCID: https://orcid.org/0000-0002-4184-5611)
- Evelien Renders
- Zibo Li (ORCID: https://orcid.org/0000-0002-1063-0298)
- Anastasia Nikolopoulou
- Thomas R. Hayes
- Isabella F. Ogilvy (ORCID: https://orcid.org/0009-0005-4303-5208)
- Inne Mortiers
Institutions
- Mansfield University (US)
- Johnson & Johnson (United States) (US)
- University Hospital of Wales (GB)
- Oxford Research Group (GB)
- University of Oxford (GB)
- Johnson & Johnson (Brazil) (BR)
- Cardiff University (GB)
Publication Details
- Journal
- Angewandte Chemie International Edition
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1002/anie.202522650
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline
- Engineering and Physical Sciences Research Council